Potential of triple-drug therapy to accelerate lymphatic filariasis elimination
Lancet Infect Dis
.
2022 Aug;22(8):1099-1100.
doi: 10.1016/S1473-3099(22)00063-9.
Epub 2022 May 6.
Author
Louise Kelly-Hope
1
Affiliation
1
Department of Livestock and One Health, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, L3 5RF, UK. Electronic address: l.kelly-hope@liverpool.ac.uk.
PMID:
35533703
DOI:
10.1016/S1473-3099(22)00063-9
No abstract available
Publication types
Comment
MeSH terms
Diethylcarbamazine / therapeutic use
Elephantiasis, Filarial* / drug therapy
Elephantiasis, Filarial* / prevention & control
Filaricides* / therapeutic use
Humans
Substances
Filaricides
Diethylcarbamazine